HEADER TRANSPORT PROTEIN 21-OCT-10 3APX TITLE CRYSTAL STRUCTURE OF THE A VARIANT OF HUMAN ALPHA1-ACID GLYCOPROTEIN TITLE 2 AND CHLORPROMAZINE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ACID GLYCOPROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AGP 2, OROSOMUCOID-2, OMD 2; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AGP2, ORM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ORIGAMI B (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3C KEYWDS BETA BARREL, PLASMA PROTEIN, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.NISHI,T.ONO,T.NAKAMURA,N.FUKUNAGA,M.IZUMI,H.WATANABE,A.SUENAGA, AUTHOR 2 T.MARUYAMA,Y.YAMAGATA,S.CURRY,M.OTAGIRI REVDAT 4 08-NOV-23 3APX 1 REMARK REVDAT 3 12-OCT-22 3APX 1 REMARK SEQADV HETSYN REVDAT 2 07-NOV-18 3APX 1 JRNL REVDAT 1 23-FEB-11 3APX 0 JRNL AUTH K.NISHI,T.ONO,T.NAKAMURA,N.FUKUNAGA,M.IZUMI,H.WATANABE, JRNL AUTH 2 A.SUENAGA,T.MARUYAMA,Y.YAMAGATA,S.CURRY,M.OTAGIRI JRNL TITL STRUCTURAL INSIGHTS INTO DIFFERENCES IN DRUG-BINDING JRNL TITL 2 SELECTIVITY BETWEEN TWO FORMS OF HUMAN ALPHA1-ACID JRNL TITL 3 GLYCOPROTEIN GENETIC VARIANTS, THE A AND F1*S FORMS. JRNL REF J. BIOL. CHEM. V. 286 14427 2011 JRNL REFN ESSN 1083-351X JRNL PMID 21349832 JRNL DOI 10.1074/JBC.M110.208926 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0099 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 8671 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.400 REMARK 3 FREE R VALUE TEST SET COUNT : 494 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 600 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE SET COUNT : 34 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1502 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 138 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.264 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.190 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.350 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1568 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2120 ; 1.100 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 178 ; 5.588 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 86 ;38.381 ;24.186 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 273 ;15.631 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;21.895 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 217 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1221 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 895 ; 0.418 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1451 ; 0.819 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 673 ; 1.225 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 669 ; 2.051 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 178 REMARK 3 ORIGIN FOR THE GROUP (A): -7.0140 -13.5210 17.5870 REMARK 3 T TENSOR REMARK 3 T11: 0.0301 T22: 0.0034 REMARK 3 T33: 0.0738 T12: 0.0066 REMARK 3 T13: 0.0005 T23: 0.0056 REMARK 3 L TENSOR REMARK 3 L11: 0.4180 L22: 0.2991 REMARK 3 L33: 0.9836 L12: -0.0198 REMARK 3 L13: 0.0025 L23: 0.1976 REMARK 3 S TENSOR REMARK 3 S11: 0.0149 S12: 0.0123 S13: 0.0428 REMARK 3 S21: -0.0307 S22: -0.0230 S23: 0.0025 REMARK 3 S31: -0.0431 S32: -0.0387 S33: 0.0081 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3APX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000029548. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9216 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3APU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.2M AMMONIUM SULFATE, REMARK 280 0.1M SODIUM ACETATE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.06250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.47850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.53850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.47850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.06250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.53850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 179 REMARK 465 GLU A 180 REMARK 465 GLY A 181 REMARK 465 GLU A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 HIS A 189 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z80 A 190 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 191 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3APU RELATED DB: PDB REMARK 900 RELATED ID: 3APV RELATED DB: PDB REMARK 900 RELATED ID: 3APW RELATED DB: PDB DBREF 3APX A 1 183 UNP P19652 A1AG2_HUMAN 19 201 SEQADV 3APX MET A 0 UNP P19652 EXPRESSION TAG SEQADV 3APX ARG A 149 UNP P19652 CYS 167 ENGINEERED MUTATION SEQADV 3APX HIS A 184 UNP P19652 EXPRESSION TAG SEQADV 3APX HIS A 185 UNP P19652 EXPRESSION TAG SEQADV 3APX HIS A 186 UNP P19652 EXPRESSION TAG SEQADV 3APX HIS A 187 UNP P19652 EXPRESSION TAG SEQADV 3APX HIS A 188 UNP P19652 EXPRESSION TAG SEQADV 3APX HIS A 189 UNP P19652 EXPRESSION TAG SEQRES 1 A 190 MET GLN ILE PRO LEU CYS ALA ASN LEU VAL PRO VAL PRO SEQRES 2 A 190 ILE THR ASN ALA THR LEU ASP ARG ILE THR GLY LYS TRP SEQRES 3 A 190 PHE TYR ILE ALA SER ALA PHE ARG ASN GLU GLU TYR ASN SEQRES 4 A 190 LYS SER VAL GLN GLU ILE GLN ALA THR PHE PHE TYR PHE SEQRES 5 A 190 THR PRO ASN LYS THR GLU ASP THR ILE PHE LEU ARG GLU SEQRES 6 A 190 TYR GLN THR ARG GLN ASN GLN CYS PHE TYR ASN SER SER SEQRES 7 A 190 TYR LEU ASN VAL GLN ARG GLU ASN GLY THR VAL SER ARG SEQRES 8 A 190 TYR GLU GLY GLY ARG GLU HIS VAL ALA HIS LEU LEU PHE SEQRES 9 A 190 LEU ARG ASP THR LYS THR LEU MET PHE GLY SER TYR LEU SEQRES 10 A 190 ASP ASP GLU LYS ASN TRP GLY LEU SER PHE TYR ALA ASP SEQRES 11 A 190 LYS PRO GLU THR THR LYS GLU GLN LEU GLY GLU PHE TYR SEQRES 12 A 190 GLU ALA LEU ASP CYS LEU ARG ILE PRO ARG SER ASP VAL SEQRES 13 A 190 MET TYR THR ASP TRP LYS LYS ASP LYS CYS GLU PRO LEU SEQRES 14 A 190 GLU LYS GLN HIS GLU LYS GLU ARG LYS GLN GLU GLU GLY SEQRES 15 A 190 GLU SER HIS HIS HIS HIS HIS HIS HET Z80 A 190 21 HET ACY A 191 4 HETNAM Z80 3-(2-CHLORO-10H-PHENOTHIAZIN-10-YL)-N,N-DIMETHYLPROPAN- HETNAM 2 Z80 1-AMINE HETNAM ACY ACETIC ACID HETSYN Z80 CHLORPROMAZINE FORMUL 2 Z80 C17 H19 CL N2 S FORMUL 3 ACY C2 H4 O2 FORMUL 4 HOH *138(H2 O) HELIX 1 1 CYS A 5 VAL A 9 5 5 HELIX 2 2 THR A 14 THR A 22 1 9 HELIX 3 3 ASN A 34 GLN A 42 1 9 HELIX 4 4 THR A 134 LEU A 148 1 15 HELIX 5 5 PRO A 151 VAL A 155 5 5 HELIX 6 6 ASP A 159 ASP A 163 5 5 HELIX 7 7 CYS A 165 LYS A 177 1 13 SHEET 1 A10 MET A 156 TYR A 157 0 SHEET 2 A10 GLY A 23 PHE A 32 -1 N SER A 30 O MET A 156 SHEET 3 A10 GLY A 123 ALA A 128 -1 O PHE A 126 N ALA A 29 SHEET 4 A10 THR A 109 SER A 114 -1 N LEU A 110 O TYR A 127 SHEET 5 A10 ARG A 95 LEU A 102 -1 N LEU A 102 O MET A 111 SHEET 6 A10 THR A 87 GLU A 92 -1 N ARG A 90 O HIS A 97 SHEET 7 A10 GLN A 71 GLN A 82 -1 N GLN A 82 O THR A 87 SHEET 8 A10 THR A 59 ARG A 68 -1 N ILE A 60 O LEU A 79 SHEET 9 A10 ILE A 44 ASN A 54 -1 N ASN A 54 O THR A 59 SHEET 10 A10 GLY A 23 PHE A 32 -1 N TYR A 27 O THR A 47 SSBOND 1 CYS A 5 CYS A 147 1555 1555 2.03 SSBOND 2 CYS A 72 CYS A 165 1555 1555 2.03 CISPEP 1 ILE A 2 PRO A 3 0 4.85 SITE 1 AC1 9 PHE A 49 PHE A 51 VAL A 88 ARG A 90 SITE 2 AC1 9 GLU A 92 HIS A 97 ALA A 99 PHE A 112 SITE 3 AC1 9 TYR A 127 SITE 1 AC2 6 VAL A 11 ARG A 20 PHE A 103 ASP A 146 SITE 2 AC2 6 ARG A 152 HOH A 202 CRYST1 42.125 63.077 64.957 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023739 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015854 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015395 0.00000